Global Institute Of Stem Cell Therapy And Research
US: +1-800-914-7836 | Mexico: +1 (619) 866-6000 | India: +91-8905483753

Archives

Author's Posts

Hollywood star Anna’s review on GIOSTAR skin serum product

Hollywood star Anna speaks about issues such as lines like on nose going up towards nose. She further says that she is hard to remain confident when things are definitely wrong. Since using the GIOSTAR skin serum product for 6 weeks, she is now better.

The lines around the eyes and right up to her forehead are getting better since using the product. She is using it on the chest, neck and thanks to the product, she is seeing reversal.

Hollywood star Anna review on GIOSTAR stem cell skin serum

Anna was diagnosed with an autoimmune condition called scleroderma in 2016. Before using GIOSTAR stem cell serum, her jaws were particularly heavy (weird). After using GIOSTAR stem cell serum therapy for 6 weeks she can see the lines diminishing around her eyes, nose.

She noticed tremendous difference especially in the neck, chest. Her other problem is that she tan very easily and get blotchy as she lives near the beach.

Ever since, using the product she can see the elasticity in the skin and blotchiness has faded. By using stem cell, skin serum from GIOSTAR is making a huge difference in the amount of recovery time and her overall appearance.

Hollywood star Anna’s reveals how GIOSTAR stem cell skin serum product improved her appearance

Hollywood star Anna talks about how her skin discoloration has reduced. The great thing about the product is that it takes about 3 minutes to do in the morning and 3 minutes at night to see the difference. She using the product for almost 7 weeks but expects to get a baby (soft) skin.

In 7 weeks, she is 80% better and 10 years younger. There is no sagging skin and elasticity is back. The moisture stays all day long and her skin never feels dry and does have bad reactions and with zero side effects.

Hollywood Star Anna’s review on GIOSTAR Ant-aging Skin Serum Therapy

Hollywood Star Anna speaks about GIOSTAR Anti-aging skin serum therapy that she has undergone. She says the person gets to the age of around 22 to 23 the human body is not able to rejuvenate and start aging.

Stem cell therapy in her opinion is the next generation therapy for making people look younger and live longer and better quality of look. She looks better, feel better and not concerned about her appearance. She says that everybody can use facial serum therapy provided by GIOSTAR to look younger and timeless.

-->

PROSPECTS OF WORLD WIDE STEM CELL THERAPY INDUSTRY IN 2027

Stem cell therapy also known as regenerative medicine is considered to transform the healthcare industry in a few years from now. Stem cells can renew themselves through mitotic cell division and differentiated into a wide range of specialized cell types.

Stem cells are found in all human beings from the early stages of human life though the number decreases with age. Stem cell therapy involves the administration of isolated cells for the treatment of diseases or traumatic damages. The advances in the field of stem cell therapy are considered to transform the healthcare industry within a few years. It is reflected by the fact that the increasing awareness related to stem cell therapy for effective disease management and growing demand for regenerative medicines is driving the stem cell therapy industry.

The Market potential of stem cell therapy industry – An overview

The stem cell therapy market was valued at US$ 1,534 million in 2019. It is estimated to reach US$ 18 billion by the end of 2028. It is expected to grow at a Compound Annual Growth Rate (CAGR) of 16.7% from 2020 to 2027.

With potential treatment procedures undergoing clinical trials and a noticiable number of stem cell therapies, having won FDA (Food and Drug Administration) approval for clinical usage is expected to fuel the growth of the stem cell therapy market.

Key factors that are driving the growth of the global stem cell therapy industry

Following factors are likely to drive the growth of the stem cell therapy industry at global level-

  • Increasing aging population,
  • Grwoing disease awareness,
  • Grwoing awareness about side-effects of conventional medicines,
  • Increasing incidences of viral and other diseases such as cancer, corona, cardiac abnormalities, organ failures etc
  • Development of banking facilities and resultant enhancement of stem cell production, storage and characterization.

The existence of stem cell based treatments has been established as a clinical standard of care for different conditions such as epithelial stem cell based therapy for burns as well as for corneal disorders and hematopoietic stem cell treatment for leukemia.

The division of global stem cell therapy market based on types-
The global stem cell therapy market is categorized based on the following types-

  • Therapy type,
  • Therapeutic area,
  • Cell type,
  • End-user,
  • Region.

Based on therapy type, the market is divided into autologous and allogenic. By therapeutic type, it is categorized into malignancies, musculoskeletal disorders, autoimmune disorders, dermatology and others.
Adult stem cell therapy held the largest market share of the market in 2020. The induced pluripotent stem cell therapy is estimated to register the highest CAGR in the market.

The region wise share of the stem cell therapy industry-

North America holds the largest share of the stem cell therapy industry. It is expected to continue this trend over the coming years. It is due, in part, to the existence of organized and developed healthcare systems, which uplift the research and development activities in the USA and Canada. Other part is contributed by the growing awareness among the patients about the curative abilities of the stem cell therapies.

The highest CAGR for stem cell therapy is likely to grow in Asia Pacific region due to the wide usage of stem cells in regenerative medicines, especially in the dermatology sector. Overall, the growing numbers of regenerative medicine centers are in turn expected to drive the stem cell therapy industry in the future.

-->

GROUNDBREAKING TREATMENT FOR SEVERE COVID-19 USING STEM CELLS

The corona virus has affected our lives ever since its emergence in late 2019 which was later declared a pandemic in 2020. Every day there is some news of death/affliction from COVID – 19 in almost every part of this planet. With a lot of research focused on developing a vaccine has resulted in a few effective ones already in production in some countries including India, and are actively being used for mass immunization. However, the vaccines are of not much importance to those already suffering from the disease.

Therefore, as needed research is also taking place for developing an effective therapeutic regimen for treating the disease. In an effort in the last few months umbilical cord blood stem cells are being used for treating severe cases of COVID-19 in clinical trials.

The University of Miami Miller School of Medicine researchers led a unique ground breaking randomized controlled trial showing umbilical cord derived from mesenchymal stem cell infusions to safely reduce the risk of death and in hastening the time to recovery for the severest COVID-19 patients.

COVID-19 induces severe inflammation in the afflicted individuals. Because of their powerful anti-inflammatory and healing properties stem cells, immaterial of the source of origin either from umbilical cord blood or the placenta or any other source, are being applied for treating patients infected with COVID-19.

The recovery from COVID – 19 after stem cell treatment

null

During the month of March, 2020, umbilical cord stem cells were intravenously administered to seven COVID-19 patients. Symptoms of all patients significantly alleviated within two days of the treatment, and no side effects were recorded. Three of these patients were discharged within 10 days after stem cell treatment. Onward the study has been expanded to treat more than thirty patients, and the results showed significant improvement in their conditions after receiving the therapy.

The rationale of using mesenchymal stem cells for treating COVID – 19

Mesenchymal stem cells, the most often used type of stem cells, are also multipotent adult stem cells present in most human tissues including the umbilical cord. These cells can self-renew while dividing, and can differentiate into multiple types of tissues leading to a robust clinical research agenda in stem cell therapy.

It has been demonstrated that mesenchymal stem cells reduce the acute lung injury and inhibit the cell-mediated inflammatory responses induced by SARS-CoV-2. Furthermore, because these cells lack the angiotensin-converting enzyme 2 (ACE2) receptor that SARS-CoV-2 uses for viral entry into cells, mesenchymal stem cells are resistant to infection.

Study of data on the use of stem cells in COVID-19

Data demonstrate that stem cells are safe and well tolerated in patients. Also, the stem cell treated patients had meaningful improvements in lung function, got off the ventilators faster than those not treated with stem cells. Stem cell treated patients experienced improved rate of survival as well.

The next step would be to study the effectiveness of stem cells in COVID-19 patients who become ill enough close to be intubated in order to determine if stem cell infusions could prevent the disease progression.
It is very likely that hyper-immune and hyper-inflammatory responses in autoimmune diseases might hold clue rooted reasons unknown about why some COVID-19 patients develop severe form of the disease while others do not.

In the month of May, 2020, the US Food and Drug Administration (FDA) also approved a phase 1/2a trial for assessing the use of umbilical cord mesenchymal stem cells for treating severe COVID-19 patients.

Make An Enquiry

We are here to help you

WordPress Video Lightbox